 Histocompatibility Testing
"Histocompatibility Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
| Descriptor ID |
D006650
|
| MeSH Number(s) |
E01.370.225.812.385 E05.200.812.385 E05.478.594.385
|
| Concept/Terms |
Histocompatibility Testing- Histocompatibility Testing
- Histocompatibility Testings
- Testing, Histocompatibility
- Testings, Histocompatibility
- Crossmatching, Tissue
- Crossmatchings, Tissue
- Tissue Crossmatching
- Tissue Crossmatchings
- Tissue Typing
- Tissue Typings
- Typing, Tissue
- Typings, Tissue
HLA Typing- HLA Typing
- HLA Typings
- Typing, HLA
- Typings, HLA
|
Below are MeSH descriptors whose meaning is more general than "Histocompatibility Testing".
Below are MeSH descriptors whose meaning is more specific than "Histocompatibility Testing".
This graph shows the total number of publications written about "Histocompatibility Testing" by people in this website by year, and whether "Histocompatibility Testing" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 | | 1998 | 1 | 1 | 2 | | 1999 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 0 | 2 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 1 | 1 | 2 | | 2007 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Histocompatibility Testing" by people in Profiles.
-
Ritari J, Hyv?rinen K, Koskela S, Niittyvuopio R, Nihtinen A, Salmenniemi U, Putkonen M, Volin L, Kwan T, Pastinen T, It?l?-Remes M, Partanen J. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT. Front Immunol. 2019; 10:1625.
-
Koskela S, Ritari J, Hyv?rinen K, Kwan T, Niittyvuopio R, It?l?-Remes M, Pastinen T, Partanen J. Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation. Sci Rep. 2018 03 29; 8(1):5396.
-
Bryan CF, Chadha V, Warady BA. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm. Pediatr Transplant. 2016 Nov; 20(7):926-930.
-
Pentz RD, Alderfer MA, Pelletier W, Stegenga K, Haight AE, Hendershot KA, Dixon M, Fairclough D, Hinds P. Unmet needs of siblings of pediatric stem cell transplant recipients. Pediatrics. 2014 May; 133(5):e1156-62.
-
Bryan CF, Luger AM, Smith JL, Warady BA, Wakefield M, Schadde E, Murillo D, Nelson PW. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant. 2010 Jan-Feb; 24(1):56-61.
-
Bryan CF, Wakefield M, Reese JC, Shield CF, Warady BA, Winklhofer FT, Murillo D. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transplant. 2007 Jan-Feb; 21(1):72-9.
-
Bryan CF, Cherikh WS, Cheng Y, Aeder MI, Muruve NA, Nelson PW, Shield CF, Warady BA, Winklhofer FT. ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney. Clin Transplant. 2004; 18 Suppl 12:55-60.
-
Bryan CF, Nelson PW, Shield CF, Ross G, Warady B, Murillo D, Winklhofer FT. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. Clin Transpl. 2004; 127-33.
-
Bryan CF, Harrell KM, Mitchell SI, Warady BA, Aeder MI, Luger AM, Murillo D, Muruve NA, Nelson PW, Shield CF. HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors. Am J Transplant. 2003 Apr; 3(4):459-64.
-
Laaksonen M, Pastinen T, Sj?roos M, Kuokkanen S, Ruutiainen J, Sumelahti ML, Reijonen H, Salonen R, Wikstr?m J, Panelius M, Partanen J, Tienari PJ, Ilonen J. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J Neuroimmunol. 2002 Jan; 122(1-2):140-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|